| Ticker | SGMO |
|---|---|
| ISIN | US8006771062 |
| Sector | Tecnología |
| Industria | Biotechnology |
| Mercado | NASDAQ |
| Capitalización | 55.926.990 € |
| Beta | 1,5 |
| Sitio web | https://www.sangamo.com |
| CEO | Alexander D. Macrae Ch.B |
| Fecha de IPO | 06/04/2000 |
| País | US |
| Dirección | 501 Canal Blvd, Richmond, CA, 94005 |
| Volumen | 17.421.394 |
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in incr...
El precio actual de Sangamo Therapeutics, Inc (SGMO) es de 0,18 , con una variación del 30,22%.
Sangamo Therapeutics, Inc opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones